CAS RN: 67130-04-5
7-chloro-1H-benzo[d][1,2,3]triazole
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Warehouse Lead Time Inquiry
Batchno.20260424
100mg / 250mg / 1g
Confirm by inquiry
Shanghai 8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 67130-04-5
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
67130-04-5 / 4-chloro-2H-benzotriazole
Standard CAS: 67130-04-5
Multi CAS: No
Basic Information
copy
CAS
67130-04-5 copy
Multi CAS
No copy
Molecular Formula
C6H4CLN3 copy
Molecular Weight
153.570000 copy
Exact Mass
153.009375 copy
InChI
InChI=1S/C6H4ClN3/c7-4-2-1-3-5-6(4)9-10-8-5/h1-3H,(H,8,9,10) copy
InChIKey
NGKNMHFWZMHABQ-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
10 copy
Aromatic heavy atom count
9 copy
H-bond acceptors
2 copy
H-bond donors
1 copy
Molar refractivity
38.9 copy
TPSA
41.57 copy
LogP / Solubility
WLOGP
1.61 copy
MLOGP
1.41 copy
XLogP3
1.7 copy
Consensus LogP
1.57 copy
Log S (ESOL)
-2.47 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-1.98 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-2 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.51 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy